miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is a severe inflammatory joint disorder, and several studies have taken note of the probability that microRNAs (miRNAs) play an important role in RA pathogenesis. MiR-146 and miR-155 arose as primary immune response regulators. Mesenchymal stem cells (MSCs) immunomodulatory function is primarily regulated by paracrine factors, such as exosomes. Exosomes, which serve as carriers of genetic information in cell-to-cell communication, transmit miRNAs between cells and have been studied as vehicles for the delivery of therapeutic molecules. AIMS: The current research aimed to investigate the therapeutic effect of miR-146a/miR-155 transduced mesenchymal stem cells (MSC)-derived exosomes on the immune response. METHODS: Here, exosomes were extracted from normal MSCs with over-expressed miR-146a/miR-155; Splenocytes were isolated from collagen-induced arthritis (CIA) and control mice. Expression levels miR-146a and miR-155 were then monitored. Flow cytometry was performed to assess the impact of the exosomes on regulatory T-cell (Treg) levels. Expression of some key autoimmune response genes and their protein products, including retinoic acid-related orphan receptor (ROR)-γt, tumor necrosis factor (TNF)-α, interleukin (IL)-17, -6, -10, and transforming growth factor (TGF)-β in the Splenocytes was determined using both quantitative real-time PCR and ELISA. The results showed that miR-146a was mainly down-regulated in CIA mice. Treatment with MSC-derived exosomes and miR-146a/miR-155-transduced MSC-derived exosomes significantly altered the CIA mice Treg cell levels compared to in control mice. RESULTS: Ultimately, such modulation may promote the recovery of appropriate T-cell responses in inflammatory situations such as RA. CONCLUSION: miR-146a-transduced MSC-derived exosomes also increased forkhead box P3 (Fox- P3), TGFβ and IL-10 gene expression in the CIA mice; miR-155 further increased the gene expressions of RORγt, IL-17, and IL-6 in these mice. Based on the findings here, Exosomes appears to promote the direct intracellular transfer of miRNAs between cells and to represent a possible therapeutic strategy for RA. The manipulation of MSC-derived exosomes with anti-inflammatory miRNA may increase Treg cell populations and anti-inflammatory cytokines.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Use of MSC-derived exosomes to load miRNAs that can alter immune responses could serve as therapeutic targets for inflammatory diseases.
“Ultimately, this modulation may facilitate the restoration of T-cell responses in rheumatoid arthritis (RA); therefore, the use of MSC-derived exosomes to load miRNAs that can alter immune responses could serve as therapeutic targets for inflammatory diseases [77].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [77]
miR-146a/miR-155-transduced MSC-derived exosome strongly increased Treg cell subpopulation and anti-inflammatory cytokines in collagen-induced arthritis mice.
“It was reported that miR-146a/miR-155-transduced MSC-derived exosome strongly increased Treg cell subpopulation and anti-inflammatory cytokines in collagen-induced arthritis (CIA) mice.”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [77]
The citation lists haven’t been fetched yet
References 65 · Cited by 125
- Authors
- Tavasolian, F., Hosseini, A. Z., Soudi, S., & Naderi, M.
- Affiliations
- Tarbiat Modares University (IR)
- Digestive Disease Research Institute (IR)
- Corresponding author
- Hosseini, Ahmad Zavaran
- Venue
- Current Gene Therapy
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2020-11-13
- Volume
- 20
- Issue
- 4
- Pages
- 297-312
- ISSN
- 1566-5232 (ISSN-L)
- OpenAlex
- W3087227373
- Cited by
- 125
- References
- 65
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 28 · 2023: 26 · 2022: 19 · 2021: 18 · 2020: 1
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Iran National Science Foundation (96005260)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Keywords
- rheumatoid arthritis, miR-146a, miR-155, mesenchymal stem cell-derived exosomes, collagen-induced arthritis, regulatory T cells, Foxp3, RORγt, Th17 cells, IL-17, interleukin-6, IL-10, TGF-beta, immunomodulation
- MeSH terms
- Animals, Arthritis, Rheumatoid, Disease Models, Animal, Female, Humans, Mice, Inbred C57BL, Cytokines, MicroRNAs, T-Lymphocytes, Regulatory, Mice, Exosomes, Immunomodulation, HEK293 Cells, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review